Evofem Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Evofem Biosciences

12/08/2021 24:07

* Evofem Biosciences Inc  EVFM.OQ  reported a quarterly adjusted
loss of 27 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 37 cents per share.
* Revenue was $1.86 million​;  analysts expected $2.68 million. 
* Evofem Biosciences Inc's reported EPS for the quarter was a
loss of 27 cents​.
* The mean earnings estimate of analysts had risen by
about 13.9% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Evofem Biosciences Inc shares had fallen by 25.0% this
quarter and lost 64.8% so far this year.
* The company reported a quarterly loss of $33.43 million.
* Wall Street's median 12-month price target for Evofem
Biosciences Inc is $4.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 11:07 p.m.  ​All
figures in US dollars unless otherwise stated